Torben Lund-hansen - Net Worth and Insider Trading
Torben Lund-hansen Net Worth
The estimated net worth of Torben Lund-hansen is at least $1 Million dollars as of 2024-09-20. Torben Lund-hansen is the SVP & CHIEF TECHNICAL OFFICER of Y-mAbs Therapeutics Inc and owns about 81,262 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $1 Million. Details can be seen in Torben Lund-hansen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Torben Lund-hansen has not made any transactions after 2024-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Torben Lund-hansen
Torben Lund-hansen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Torben Lund-hansen owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .
Click here to see the complete history of Torben Lund-hansen’s form 4 insider trades.
Insider Ownership Summary of Torben Lund-hansen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| YMAB | Y-mAbs Therapeutics Inc | 2024-08-28 | Sr. VP and Head of Tech Op |
Torben Lund-hansen Latest Holdings Summary
Torben Lund-hansen currently owns a total of 1 stock. Torben Lund-hansen owns 81,262 shares of Y-mAbs Therapeutics Inc (YMAB) as of August 28, 2024, with a value of $1 Million.
Latest Holdings of Torben Lund-hansen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| YMAB | Y-mAbs Therapeutics Inc | 2024-08-28 | 81,262 | 14.00 | 1,137,668 |
Holding Weightings of Torben Lund-hansen
Torben Lund-hansen Form 4 Trading Tracker
According to the SEC Form 4 filings, Torben Lund-hansen has made a total of 1 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the sale of 50,000 shares on August 28, 2024, which brought Torben Lund-hansen around $768,500.
Insider Trading History of Torben Lund-hansen
- 1
Torben Lund-hansen Trading Performance
Torben Lund-hansen Ownership Network
Torben Lund-hansen Owned Company Details
What does Y-mAbs Therapeutics Inc do?
Who are the key executives at Y-mAbs Therapeutics Inc?
Torben Lund-hansen is the Sr. VP and Head of Tech Op of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include director & President and Chairman Thomas Gad , Sr. VP and COO Joris Wilms , and director & EVP & CFO & Secy & Treas. Bo Kruse .
Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary
Over the past 18 months, Torben Lund-hansen made 1 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net sale of 50,000. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net sale of 501,251 shares made by Thomas Gad , a net purchase of 380,768 shares made by Johan Wedell-wedellsborg , and a net purchase of 380,768 shares made by Biotech Aps Wg .
In summary, during the past 3 months, insiders sold 150,000 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 150,000 shares. During the past 18 months, 620,366 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 761,536 shares were bought by its insiders, resulting in a net purchase of 141,170 shares.
Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Y-mAbs Therapeutics Inc Insider Transactions
Torben Lund-hansen Mailing Address
Above is the net worth, insider trading, and ownership report for Torben Lund-hansen. You might contact Torben Lund-hansen via mailing address: C/o Y-mabs Therapeutics, Inc., 230 Park Avenue, 33rd Floor, New York Ny 10169.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
